Thyroid remnant ablation in differentiated thyroid carcinoma: when and how
Tóm tắt
131I ablation is considered an effective and safe adjuvant therapy modality for differentiated thyroid cancer (DTC), although there is an ongoing debate about the need for 131I ablation in patients without lymph node or distant metastases and with low stages of the primary (pT1-2) tumor. However, on the basis of evidence from retrospective studies and pending the results of ongoing controlled prospective randomized trials, it seems advisable to perform 131I remnant ablation in patients with primary tumors >1 cm. For thyroid remnant ablation, individual dosimetry is not generally considered necessary, but it may improve success rates if used according to strict criteria. The use of recombinant human TSH (rhTSH) for patient preparation allows maintenance of quality of life and results in a lower radiation exposure of healthy non-thyroid tissue compared with TSH stimulation through levothyroxine withdrawal. This approach has been approved for 131I ablation, but not for 131I therapy of distant metastases.
Tài liệu tham khảo
citation_journal_title=Thyroid; citation_title=Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer; citation_author=DS Cooper, GM Doherty, BR Haugen, RT Kloos, SL Lee, SJ Mandel, EL Mazzaferri, B McIver, F Pacini, M Schlumberger, SI Sherman, DL Steward, RM Tuttle; citation_volume=19; citation_publication_date=2009; citation_pages=1167-1214; citation_doi=10.1089/thy.2009.0110; citation_id=CR1
citation_journal_title=Eur J Endocrinol; citation_title=European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium; citation_author=F Pacini, M Schlumberger, H Dralle, R Elisei, JW Smit, W Wiersinga; citation_volume=154; citation_publication_date=2006; citation_pages=787-803; citation_doi=10.1530/eje.1.02158; citation_id=CR2
citation_journal_title=Ann Oncol; citation_title=Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up; citation_author=F Pacini, MG Castagna, L Brilli, G Pentheroudakis; citation_volume=21; citation_issue=Suppl 5; citation_publication_date=2010; citation_pages=v214-v219; citation_doi=10.1093/annonc/mdq190; citation_id=CR3
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Guidelines for radioiodine therapy of differentiated thyroid cancer; citation_author=M Luster, SE Clarke, M Dietlein, M Lassmann, P Lind, WJ Oyen, J Tennvall, E Bombardieri; citation_volume=35; citation_publication_date=2008; citation_pages=1941-1959; citation_doi=10.1007/s00259-008-0883-1; citation_id=CR4
citation_journal_title=Clin Endocrinol (Oxf); citation_title=Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma; citation_author=S Diessl, B Holzberger, U Mader, I Grelle, JW Smit, AK Buck, C Reiners, FA Verburg; citation_volume=76; citation_publication_date=2012; citation_pages=586-592; citation_doi=10.1111/j.1365-2265.2011.04272.x; citation_id=CR5
citation_journal_title=Endocr Pract; citation_title=American association of clinical endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules; citation_author=; citation_volume=12; citation_publication_date=2006; citation_pages=63-102; citation_id=CR6
citation_journal_title=Langenbecks Arch Surg; citation_title=German association of endocrine surgeons practice guidelines for the surgical treatment of benign thyroid disease; citation_author=TJ Musholt, T Clerici, H Dralle, A Frilling, PE Goretzki, MM Hermann, J Kussmann, K Lorenz, C Nies, J Schabram, P Schabram, C Scheuba, D Simon, T Steinmuller, AW Trupka, RA Wahl, A Zielke, A Bockisch, W Karges, M Luster, KW Schmid; citation_volume=396; citation_publication_date=2011; citation_pages=639-649; citation_doi=10.1007/s00423-011-0774-y; citation_id=CR7
citation_journal_title=Am J Med; citation_title=Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer; citation_author=EL Mazzaferri, SM Jhiang; citation_volume=97; citation_publication_date=1994; citation_pages=418-428; citation_doi=10.1016/0002-9343(94)90321-2; citation_id=CR8
citation_journal_title=Nat Rev Endocrinol; citation_title=Radioiodine for remnant ablation and therapy of metastatic disease; citation_author=C Reiners, H Hanscheid, M Luster, M Lassmann, FA Verburg; citation_volume=7; citation_publication_date=2011; citation_pages=589-595; citation_doi=10.1038/nrendo.2011.134; citation_id=CR9
citation_journal_title=J Clin Endocrinol Metab; citation_title=Life expectancy is reduced in differentiated thyroid cancer patients ≥45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients; citation_author=FA Verburg, U Mader, K Tanase, ED Thies, S Diessl, AK Buck, M Luster, C Reiners; citation_volume=98; citation_publication_date=2013; citation_pages=172-180; citation_doi=10.1210/jc.2012-2458; citation_id=CR10
citation_journal_title=Eur J Endocrinol; citation_title=Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients; citation_author=FA Verburg, B Keizer, CJ Lips, PM Zelissen, JM Klerk; citation_volume=152; citation_publication_date=2005; citation_pages=33-37; citation_doi=10.1530/eje.1.01819; citation_id=CR11
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer; citation_author=FA Verburg, MP Stokkel, C Duren, RB Verkooijen, U Mader, JW Isselt, RJ Marlowe, JW Smit, C Reiners, M Luster; citation_volume=37; citation_publication_date=2010; citation_pages=276-283; citation_doi=10.1007/s00259-009-1315-6; citation_id=CR12
citation_journal_title=J Biol Chem; citation_title=Thyroid Na +/I- symporter. Mechanism, stoichiometry, and specificity; citation_author=S Eskandari, DD Loo, G Dai, O Levy, EM Wright, N Carrasco; citation_volume=272; citation_publication_date=1997; citation_pages=27230-27238; citation_doi=10.1074/jbc.272.43.27230; citation_id=CR13
citation_journal_title=N Engl J Med; citation_title=Papillary and follicular thyroid carcinoma; citation_author=MJ Schlumberger; citation_volume=338; citation_publication_date=1998; citation_pages=297-306; citation_doi=10.1056/NEJM199801293380506; citation_id=CR14
citation_journal_title=J Clin Endocrinol Metab; citation_title=Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer; citation_author=EL Mazzaferri, RT Kloos; citation_volume=86; citation_publication_date=2001; citation_pages=1447-1463; citation_doi=10.1210/jc.86.4.1447; citation_id=CR15
citation_journal_title=Cancer; citation_title=Long-term results and prognostic factors in patients with differentiated thyroid carcinoma; citation_author=M Tubiana, M Schlumberger, P Rougier, A Laplanche, E Benhamou, P Gardet, B Caillou, JP Travagli, C Parmentier; citation_volume=55; citation_publication_date=1985; citation_pages=794-804; citation_doi=10.1002/1097-0142(19850215)55:4<794::AID-CNCR2820550418>3.0.CO;2-Z; citation_id=CR16
citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Papillary and follicular thyroid cancer: impact of treatment in 1578 patients; citation_author=WJ Simpson, T Panzarella, JS Carruthers, MK Gospodarowicz, SB Sutcliffe; citation_volume=14; citation_publication_date=1988; citation_pages=1063-1075; citation_doi=10.1016/0360-3016(88)90381-1; citation_id=CR17
citation_journal_title=N Engl J Med; citation_title=Follow-up of patients with thyroid carcinoma; citation_author=RD Utiger; citation_volume=337; citation_publication_date=1997; citation_pages=928-930; citation_doi=10.1056/NEJM199709253371311; citation_id=CR18
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma; citation_author=FA Verburg, M Dietlein, M Lassmann, M Luster, C Reiners; citation_volume=36; citation_publication_date=2009; citation_pages=343-346; citation_doi=10.1007/s00259-008-0997-5; citation_id=CR19
citation_journal_title=N Engl J Med; citation_title=Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma; citation_author=TM Shattuck, WH Westra, PW Ladenson, A Arnold; citation_volume=352; citation_publication_date=2005; citation_pages=2406-2412; citation_doi=10.1056/NEJMoa044190; citation_id=CR20
citation_journal_title=J Clin Endocrinol Metab; citation_title=Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma; citation_author=SI Sherman, ET Tielens, S Sostre, MD Wharam, PW Ladenson; citation_volume=78; citation_publication_date=1994; citation_pages=629-634; citation_doi=10.1210/jc.78.3.629; citation_id=CR21
citation_journal_title=Eur J Cancer; citation_title=Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease; citation_author=F Tenenbaum, C Corone, M Schlumberger, C Parmentier; citation_volume=32A; citation_publication_date=1996; citation_pages=1262; citation_doi=10.1016/0959-8049(96)00020-2; citation_id=CR22
citation_journal_title=J Clin Endocrinol Metab; citation_title=Combination of radioiodine 131I and probe-guided surgery for persistent or recurrent thyroid carcinoma; citation_author=JP Travagli, AF Cailleux, M Ricard, E Baudin, B Caillou, C Parmentier, M Schlumberger; citation_volume=83; citation_publication_date=1998; citation_pages=2675-2680; citation_doi=10.1210/jc.83.8.2675; citation_id=CR23
citation_journal_title=Ann Intern Med; citation_title=Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma; citation_author=T Taylor, B Specker, J Robbins, M Sperling, M Ho, K Ain, ST Bigos, J Brierley, D Cooper, B Haugen, I Hay, V Hertzberg, I Klein, H Klein, P Ladenson, R Nishiyama, D Ross, S Sherman, HR Maxon; citation_volume=129; citation_publication_date=1998; citation_pages=622-627; citation_doi=10.7326/0003-4819-129-8-199810150-00007; citation_id=CR24
citation_journal_title=World J Surg; citation_title=Papillary thyroid carcinoma managed at the Mayo clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients; citation_author=ID Hay, GB Thompson, CS Grant, EJ Bergstralh, CE Dvorak, CA Gorman, MS Maurer, B McIver, BP Mullan, AL Oberg, CC Powell, JA Heerden, JR Goellner; citation_volume=26; citation_publication_date=2002; citation_pages=879-885; citation_doi=10.1007/s00268-002-6612-1; citation_id=CR25
citation_journal_title=J Clin Endocrinol Metab; citation_title=Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer; citation_author=AM Sawka, K Thephamongkhol, M Brouwers, L Thabane, G Browman, HC Gerstein; citation_volume=89; citation_publication_date=2004; citation_pages=3668-3676; citation_doi=10.1210/jc.2003-031167; citation_id=CR26
citation_journal_title=Eur J Endocrinol; citation_title=Post-surgical use of radioiodine 131I in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report; citation_author=F Pacini, M Schlumberger, C Harmer, GG Berg, O Cohen, L Duntas, F Jamar, B Jarzab, E Limbert, P Lind, C Reiners, FF Sanchez, J Smit, W Wiersinga; citation_volume=153; citation_publication_date=2005; citation_pages=651-659; citation_doi=10.1530/eje.1.02014; citation_id=CR27
citation_journal_title=Thyroid; citation_title=Is adjuvant therapy useful in patients with papillary carcinoma smaller than 2 cm?; citation_author=PW Rosario, MA Borges, MM Valadao, FP Vasconcelos, LL Rezende, EL Padrao, AL Barroso, S Purisch; citation_volume=17; citation_publication_date=2007; citation_pages=1225-1228; citation_doi=10.1089/thy.2006.0254; citation_id=CR28
citation_journal_title=Endocrinol Metab Clin North Am; citation_title=An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer; citation_author=AM Sawka, JD Brierley, RW Tsang, L Thabane, L Rotstein, A Gafni, S Straus, DP Goldstein; citation_volume=37; citation_publication_date=2008; citation_pages=457-480; citation_doi=10.1016/j.ecl.2008.02.007; citation_id=CR29
citation_journal_title=Thyroid; citation_title=Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis; citation_author=AM Sawka, L Thabane, L Parlea, I Ibrahim-Zada, RW Tsang, JD Brierley, S Straus, S Ezzat, DP Goldstein; citation_volume=19; citation_publication_date=2009; citation_pages=451-457; citation_doi=10.1089/thy.2008.0392; citation_id=CR30
citation_journal_title=Thyroid; citation_title=Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis; citation_author=S Subramanian, DP Goldstein, L Parlea, L Thabane, S Ezzat, I Ibrahim-Zada, S Straus, JD Brierley, RW Tsang, A Gafni, L Rotstein, AM Sawka; citation_volume=17; citation_publication_date=2007; citation_pages=1277-1288; citation_doi=10.1089/thy.2007.0171; citation_id=CR31
citation_journal_title=Cancer; citation_title=The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer; citation_author=MR Haymart, M Banerjee, D Yang, AK Stewart, RJ Koenig, JJ Griggs; citation_volume=119; citation_publication_date=2013; citation_pages=259-265; citation_doi=10.1002/cncr.27721; citation_id=CR32
citation_journal_title=J Clin Endocrinol Metab; citation_title=Morbidity and mortality in follicular thyroid cancer; citation_author=LJ DeGroot, EL Kaplan, MS Shukla, G Salti, FH Straus; citation_volume=80; citation_publication_date=1995; citation_pages=2946-2953; citation_doi=10.1210/jc.80.10.2946; citation_id=CR33
citation_journal_title=J Clin Endocrinol Metab; citation_title=The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients; citation_author=NA Samaan, PN Schultz, RC Hickey, H Goepfert, TP Haynie, DA Johnston, NG Ordonez; citation_volume=75; citation_publication_date=1992; citation_pages=714-720; citation_doi=10.1210/jc.75.3.714; citation_id=CR34
citation_journal_title=JAMA; citation_title=Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid; citation_author=SM Seidlin, LD Marinelli, E Oshry; citation_volume=132; citation_publication_date=1946; citation_pages=838-847; citation_doi=10.1001/jama.1946.02870490016004; citation_id=CR35
citation_journal_title=Clin Endocrinol (Oxf); citation_title=Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer; citation_author=SA Doi, NJ Woodhouse; citation_volume=52; citation_publication_date=2000; citation_pages=765-773; citation_doi=10.1046/j.1365-2265.2000.01014.x; citation_id=CR36
citation_journal_title=J Clin Endocrinol Metab; citation_title=
131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review; citation_author=A Hackshaw, C Harmer, U Mallick, M Haq, JA Franklyn; citation_volume=92; citation_publication_date=2007; citation_pages=28-38; citation_doi=10.1210/jc.2006-1345; citation_id=CR37
citation_journal_title=Clin Med Res; citation_title=Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited; citation_author=SA Doi, NJ Woodhouse, L Thalib, A Onitilo; citation_volume=5; citation_publication_date=2007; citation_pages=87-90; citation_doi=10.3121/cmr.2007.763; citation_id=CR38
citation_journal_title=J Clin Endocrinol Metab; citation_title=Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis; citation_author=W Cheng, C Ma, H Fu, J Li, S Chen, S Wu, H Wang; citation_volume=98; citation_publication_date=2013; citation_pages=1353-1360; citation_doi=10.1210/jc.2012-3682; citation_id=CR39
citation_journal_title=N Engl J Med; citation_title=Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer; citation_author=U Mallick, C Harmer, B Yap, J Wadsley, S Clarke, L Moss, A Nicol, PM Clark, K Farnell, R McCready, J Smellie, JA Franklyn, R John, CM Nutting, K Newbold, C Lemon, G Gerrard, A Abdel-Hamid, J Hardman, E Macias, T Roques, S Whitaker, R Vijayan, P Alvarez, S Beare, S Forsyth, L Kadalayil, A Hackshaw; citation_volume=366; citation_publication_date=2012; citation_pages=1674-1685; citation_doi=10.1056/NEJMoa1109589; citation_id=CR40
citation_journal_title=N Engl J Med; citation_title=Strategies of radioiodine ablation in patients with low-risk thyroid cancer; citation_author=M Schlumberger, B Catargi, I Borget, D Deandreis, S Zerdoud, B Bridji, S Bardet, L Leenhardt, D Bastie, C Schvartz, P Vera, O Morel, D Benisvy, C Bournaud, F Bonichon, C Dejax, ME Toubert, S Leboulleux, M Ricard, E Benhamou; citation_volume=366; citation_publication_date=2012; citation_pages=1663-1673; citation_doi=10.1056/NEJMoa1108586; citation_id=CR41
citation_journal_title=Thyroid; citation_title=In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 mU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin; citation_author=LA Valle, RL Gorodeski Baskin, K Porter, JA Sipos, R Khawaja, MD Ringel, RT Kloos; citation_volume=23; citation_publication_date=2013; citation_pages=185-193; citation_doi=10.1089/thy.2012.0327; citation_id=CR42
citation_journal_title=J Clin Endocrinol Metab; citation_title=Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study; citation_author=F Pacini, PW Ladenson, M Schlumberger, A Driedger, M Luster, RT Kloos, S Sherman, B Haugen, C Corone, E Molinaro, R Elisei, C Ceccarelli, A Pinchera, RL Wahl, S Leboulleux, M Ricard, J Yoo, NL Busaidy, E Delpassand, H Hanscheid, R Felbinger, M Lassmann, C Reiners; citation_volume=91; citation_publication_date=2006; citation_pages=926-932; citation_doi=10.1210/jc.2005-1651; citation_id=CR43
citation_journal_title=Nuklearmedizin; citation_title=Improved follow-up of patients with differentiated thyroid carcinoma. The quantitative detection limit of 131I uptake in diagnostic scans; citation_author=S Diessl, F Verburg, J Biko, B Schryen, C Reiners, A Buck, H Hanscheid; citation_volume=52; citation_publication_date=2013; citation_pages=81-87; citation_id=CR44
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level; citation_author=H Hanscheid, FA Verburg, J Biko, S Diessl, YE Demidchik, V Drozd, C Reiners; citation_volume=38; citation_publication_date=2011; citation_pages=1296-1302; citation_doi=10.1007/s00259-011-1788-y; citation_id=CR45
citation_journal_title=Clin Oncol (R Coll Radiol); citation_title=Iodine or Not (IoN) for low-risk differentiated thyroid cancer: the next UK national cancer research network randomised trial following HiLo; citation_author=U Mallick, C Harmer, A Hackshaw, L Moss; citation_volume=24; citation_publication_date=2012; citation_pages=159-161; citation_doi=10.1016/j.clon.2012.01.001; citation_id=CR46
citation_journal_title=J Nucl Med; citation_title=Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal; citation_author=H Hanscheid, M Lassmann, M Luster, SR Thomas, F Pacini, C Ceccarelli, PW Ladenson, RL Wahl, M Schlumberger, M Ricard, A Driedger, RT Kloos, SI Sherman, BR Haugen, V Carriere, C Corone, C Reiners; citation_volume=47; citation_publication_date=2006; citation_pages=654; citation_id=CR47
citation_journal_title=J Nucl Med; citation_title=Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer; citation_author=AM Samuel, B Rajashekharrao, DH Shah; citation_volume=39; citation_publication_date=1998; citation_pages=1531-1536; citation_id=CR48
citation_journal_title=Q J Nucl Med Mol Imaging; citation_title=Individualized dosimetry in the management of metastatic differentiated thyroid cancer; citation_author=C Chiesa, MR Castellani, C Vellani, E Orunesu, A Negri, R Azzeroni, F Botta, M Maccauro, G Aliberti, E Seregni, M Lassmann, E Bombardieri; citation_volume=53; citation_publication_date=2009; citation_pages=546-561; citation_id=CR49
citation_journal_title=AJR; citation_title=The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer; citation_author=RS Benua, NR Cicale, M Sonenberg, RW Rawson; citation_volume=1962; citation_publication_date=1962; citation_pages=171-182; citation_id=CR50
citation_journal_title=J Nucl Med; citation_title=Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach; citation_author=R Dorn, J Kopp, H Vogt, P Heidenreich, RG Carroll, SA Gulec; citation_volume=44; citation_publication_date=2003; citation_pages=451-456; citation_id=CR51
citation_journal_title=J Nucl Med; citation_title=Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer; citation_author=RM Tuttle, R Leboeuf, RJ Robbins, R Qualey, K Pentlow, SM Larson, CY Chan; citation_volume=47; citation_publication_date=2006; citation_pages=1587-1591; citation_id=CR52
citation_journal_title=Thyroid; citation_title=The relative frequency in which empiric dosages of radioiodine would potentially overtreat or under treat patients who have metastatic well-differentiated thyroid cancer; citation_author=K Kulkarni, D Nostrand, F Atkins, M Aiken, K Burman, L Wartofsky; citation_volume=16; citation_publication_date=2006; citation_pages=1019-1023; citation_doi=10.1089/thy.2006.16.1019; citation_id=CR53
citation_journal_title=Endocr Relat Cancer; citation_title=Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma; citation_author=H Hanscheid, M Lassmann, M Luster, R Kloos, C Reiners; citation_volume=16; citation_publication_date=2009; citation_pages=1283-1289; citation_id=CR54
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patients; citation_author=FA Verburg, M Lassmann, U Mader, M Luster, C Reiners, H Hanscheid; citation_volume=38; citation_publication_date=2011; citation_pages=673-680; citation_doi=10.1007/s00259-010-1689-5; citation_id=CR55
citation_journal_title=N Engl J Med; citation_title=Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer; citation_author=HR Maxon, SR Thomas, VS Hertzberg, JG Kereiakes, IW Chen, MI Sperling, EL Saenger; citation_volume=309; citation_publication_date=1983; citation_pages=937-941; citation_doi=10.1056/NEJM198310203091601; citation_id=CR56
citation_journal_title=J Nucl Med; citation_title=Radioiodine-131 therapy for well-differentiated thyroid cancer–a quantitative radiation dosimetric approach: outcome and validation in 85 patients; citation_author=HR Maxon, EE Englaro, SR Thomas, VS Hertzberg, JD Hinnefeld, LS Chen, H Smith, D Cummings, MD Aden; citation_volume=33; citation_publication_date=1992; citation_pages=1132-1136; citation_id=CR57
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer; citation_author=GD Flux, M Haq, SJ Chittenden, S Buckley, C Hindorf, K Newbold, CL Harmer; citation_volume=37; citation_publication_date=2010; citation_pages=270-275; citation_doi=10.1007/s00259-009-1261-3; citation_id=CR58
citation_journal_title=J Nucl Med; citation_title=Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software; citation_author=G Sgouros, KS Kolbert, A Sheikh, KS Pentlow, EF Mun, A Barth, RJ Robbins, SM Larson; citation_volume=45; citation_publication_date=2004; citation_pages=1366-1372; citation_id=CR59
citation_journal_title=Endocr Relat Cancer; citation_title=Dosimetry and thyroid cancer: the individual dosage of radioiodine; citation_author=M Lassmann, C Reiners, M Luster; citation_volume=17; citation_publication_date=2010; citation_pages=R161-R172; citation_doi=10.1677/ERC-10-0071; citation_id=CR60
citation_journal_title=J Nucl Med; citation_title=MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry–standardization of nomenclature; citation_author=WE Bolch, KF Eckerman, G Sgouros, SR Thomas; citation_volume=50; citation_publication_date=2009; citation_pages=477-484; citation_doi=10.2967/jnumed.108.056036; citation_id=CR61
citation_journal_title=J Nucl Med; citation_title=Three-dimensional radiobiologic dosimetry: application of radiobiologic modelling to patient-specific 3-dimensional imaging-based internal dosimetry; citation_author=AR Prideaux, H Song, RF Hobbs, B He, EC Frey, PW Ladenson, RL Wahl, G Sgouros; citation_volume=48; citation_publication_date=2007; citation_pages=1008-1016; citation_doi=10.2967/jnumed.106.038000; citation_id=CR62
citation_journal_title=Clin Nucl Med; citation_title=Low iodine diet in I-131 ablation of thyroid remnants; citation_author=HR Maxon, SR Thomas, A Boehringer, J Drilling, MI Sperling, JC Sparks, IW Chen; citation_volume=8; citation_publication_date=1983; citation_pages=123-126; citation_doi=10.1097/00003072-198303000-00006; citation_id=CR63
citation_journal_title=Endocr Pract; citation_title=Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey; citation_author=AM Sawka, DP Goldstein, L Thabane, JD Brierley, RW Tsang, L Rotstein, S Kamalanathan, B Zhao, A Gafni, S Straus, S Ezzat; citation_volume=14; citation_publication_date=2008; citation_pages=175-184; citation_doi=10.4158/EP.14.2.175; citation_id=CR64
citation_journal_title=Thyroid; citation_title=Two weeks of a low-iodine diet are equivalent to 3 weeks for lowering urinary iodine and increasing thyroid radioactive iodine uptake; citation_author=EP Morsch, R Vanacor, TW Furlanetto, H Schmid; citation_volume=21; citation_publication_date=2011; citation_pages=61-67; citation_doi=10.1089/thy.2010.0232; citation_id=CR65
citation_journal_title=Thyroid; citation_title=Development and in vitro characterization of human recombinant thyrotropin; citation_author=BD Weintraub, MW Szkudlinski; citation_volume=9; citation_publication_date=1999; citation_pages=447-450; citation_doi=10.1089/thy.1999.9.447; citation_id=CR66
citation_journal_title=J Clin Endocrinol Metab; citation_title=A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer; citation_author=BR Haugen, F Pacini, C Reiners, M Schlumberger, PW Ladenson, SI Sherman, DS Cooper, KE Graham, LE Braverman, MC Skarulis, TF Davies, LJ DeGroot, EL Mazzaferri, GH Daniels, DS Ross, M Luster, MH Samuels, DV Becker, HR Maxon, RR Cavalieri, CA Spencer, K McEllin, BD Weintraub, EC Ridgway; citation_volume=84; citation_publication_date=1999; citation_pages=3877-3885; citation_doi=10.1210/jc.84.11.3877; citation_id=CR67
citation_journal_title=Eur J Endocrinol; citation_title=Short-term hypothyroidism after levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences; citation_author=LH Duntas, B Biondi; citation_volume=156; citation_publication_date=2007; citation_pages=13-19; citation_doi=10.1530/eje.1.02310; citation_id=CR68
citation_journal_title=Thyroid; citation_title=Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomics comparison to recombinant thyrotropin administration; citation_author=M Luster, R Felbinger, M Dietlein, C Reiners; citation_volume=15; citation_publication_date=2005; citation_pages=1147-1155; citation_doi=10.1089/thy.2005.15.1147; citation_id=CR69
citation_journal_title=Thyroid; citation_title=Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy; citation_author=KH Dow, BR Ferrell, C Anello; citation_volume=7; citation_publication_date=1997; citation_pages=613-619; citation_doi=10.1089/thy.1997.7.613; citation_id=CR70
citation_journal_title=J Clin Endocrinol Metab; citation_title=A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal; citation_author=PR Schroeder, BR Haugen, F Pacini, C Reiners, M Schlumberger, SI Sherman, DS Cooper, KG Schuff, LE Braverman, MC Skarulis, TF Davies, EL Mazzaferri, GH Daniels, DS Ross, M Luster, MH Samuels, BD Weintraub, EC Ridgway, PW Ladenson; citation_volume=91; citation_publication_date=2006; citation_pages=878-884; citation_doi=10.1210/jc.2005-2064; citation_id=CR71
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma; citation_author=M Luster, SI Sherman, MC Skarulis, JR Reynolds, M Lassmann, H Hanscheid, C Reiners; citation_volume=30; citation_publication_date=2003; citation_pages=1371-1377; citation_doi=10.1007/s00259-003-1230-1; citation_id=CR72
citation_journal_title=J Nucl Med; citation_title=Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radio toxicity; citation_author=PW Rosario, MA Borges, S Purisch; citation_volume=49; citation_publication_date=2008; citation_pages=1776-1782; citation_doi=10.2967/jnumed.108.050591; citation_id=CR73
citation_journal_title=J Clin Endocrinol Metab; citation_title=Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal; citation_author=A Frigo, A Dardano, E Danese, MV Davi, P Moghetti, C Colato, G Francia, F Bernardi, C Traino, F Monzani, M Ferdeghini; citation_volume=94; citation_publication_date=2009; citation_pages=3472-3476; citation_doi=10.1210/jc.2008-2830; citation_id=CR74
citation_journal_title=Onco Targets Ther; citation_title=Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management; citation_author=A Gramza, KG Schuff; citation_volume=1; citation_publication_date=2009; citation_pages=87-101; citation_id=CR75
citation_journal_title=J Clin Endocrinol Metab; citation_title=Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal; citation_author=R Elisei, M Schlumberger, A Driedger, C Reiners, RT Kloos, SI Sherman, B Haugen, C Corone, E Molinaro, L Grasso, S Leboulleux, I Rachinsky, M Luster, M Lassmann, NL Busaidy, RL Wahl, F Pacini, SY Cho, J Magner, A Pinchera, PW Ladenson; citation_volume=94; citation_publication_date=2009; citation_pages=4171-4179; citation_doi=10.1210/jc.2009-0869; citation_id=CR76
citation_journal_title=J Nucl Med; citation_title=Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal; citation_author=RM Tuttle, M Brokhin, G Omry, AJ Martorella, SM Larson, RK Grewal, M Fleisher, RJ Robbins; citation_volume=49; citation_publication_date=2008; citation_pages=764-770; citation_doi=10.2967/jnumed.107.049072; citation_id=CR77
citation_journal_title=J Clin Endocrinol Metab; citation_title=Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma; citation_author=M Luster, M Lassmann, H Haenscheid, U Michalowski, C Incerti, C Reiners; citation_volume=85; citation_publication_date=2000; citation_pages=3640-3645; citation_doi=10.1210/jc.85.10.3640; citation_id=CR78
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy; citation_author=B Keizer, B Brans, A Hoekstra, PM Zelissen, HP Koppeschaar, CJ Lips, PP Rijk, RA Dierckx, JM Klerk; citation_volume=30; citation_publication_date=2003; citation_pages=367-373; citation_doi=10.1007/s00259-002-1076-y; citation_id=CR79
citation_journal_title=Thyroid; citation_title=Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine; citation_author=RJ Robbins, A Driedger, J Magner; citation_volume=16; citation_publication_date=2006; citation_pages=1121-1130; citation_doi=10.1089/thy.2006.16.1121; citation_id=CR80
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen; citation_author=I Borget, H Remy, J Chevalier, M Ricard, M Allyn, M Schlumberger, G Pouvourville; citation_volume=35; citation_publication_date=2008; citation_pages=1457-1463; citation_doi=10.1007/s00259-008-0754-9; citation_id=CR81
citation_journal_title=Eur J Endocrinol; citation_title=Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with thyrogen and thyroid hormone withdrawal; citation_author=I Borget, C Corone, M Nocaudie, M Allyn, S Iacobelli, M Schlumberger, G Pouvourville; citation_volume=156; citation_publication_date=2007; citation_pages=531-538; citation_doi=10.1530/EJE-06-0724; citation_id=CR82
citation_journal_title=Eur J Endocrinol; citation_title=Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective; citation_author=P Mernagh, S Campbell, M Dietlein, M Luster, E Mazzaferri, AR Weston; citation_volume=155; citation_publication_date=2006; citation_pages=405-414; citation_doi=10.1530/eje.1.02223; citation_id=CR83
citation_journal_title=Minerva Endocrinol; citation_title=Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin; citation_author=P Zanotti-Fregonara, ME Toubert, D Taieb, L Ravasi, D Rubello, E Hindie; citation_volume=33; citation_publication_date=2008; citation_pages=53-65; citation_id=CR84
citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium; citation_author=D Barbaro, M Grosso, G Boni, D Volterrani, P Lapi, C Pasquini, P Orsini, A Turco, G Meucci, MC Marzola, P Berti, P Miccoli, G Mariani, D Rubello; citation_volume=37; citation_publication_date=2009; citation_pages=242-249; citation_doi=10.1007/s00259-009-1254-2; citation_id=CR85
citation_journal_title=J Clin Endocrinol Metab; citation_title=Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients; citation_author=HP Tala Jury, MG Castagna, C Fioravanti, C Cipri, E Brianzoni, F Pacini; citation_volume=95; citation_publication_date=2010; citation_pages=230-237; citation_doi=10.1210/jc.2009-1624; citation_id=CR86